| 英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
|---|---|---|---|---|---|---|
|
L-701,252
|
151057-13-5 |
盐酸Org 12962
|
|
C13H10NO3Cl |
263.6764 | |
|
(S)-4-Carboxy-3-hydroxyphenylglycine
|
85148-82-9 |
GR 231118
|
|
C9H9NO5 |
211.17 | |
|
Pluripotin (SC-1)
|
839707-37-8 |
PLURIPOTIN
|
N-[3-[7-[(1,3-二甲基-1H-吡唑-5-基)氨基]-1,4-二氢-1-甲基-2-氧代嘧啶并[4,5-D]嘧啶-3(2H)-基]-4-甲基苯基]-3-(三氟甲基)苯甲酰胺;CS-2337;CS-2160
|
C27H25N8O2F3 |
550.535 | 804-647-7 |
|
GNF-7
|
839706-07-9 |
GNF-7
|
N-[3-[1,4-二氢-1-甲基-7-[(6-甲基-3-吡啶基)氨基]-2-氧代嘧啶并[4,5-D]嘧啶-3(2H)-基]-4-甲基苯基]-3-(三氟甲基)苯甲酰胺;CS-1945;GNF-7>98%
|
C28H24N7O2F3 |
547.53106 | |
|
NS 11021
|
956014-19-0 |
N'-[3,5-BIS(TRIFLUOROMETHYL)PHENYL]-N-[4-BROMO-2-(2H-TETRAZOL-5-YL-PHENYL]THIOUREA
|
N'-[3,5-双(三氟甲基)苯基]-N-[4-溴-2-(2H-四唑-5-基)苯基]-硫脲
|
C16H9BrF6N6S |
511.242279 | |
|
CZC-25146
|
1191911-26-8 |
CZC25146
|
LRRK2 INHIBITOR II;CZC25146;CZC 25146
|
C22H25FN6O4S |
488.535103 | |
|
CZC-54252
|
1191911-27-9 |
CZC-54252
|
CZC-54252, >98%;N-[2-[[5-Chloro-2-[[2-methoxy-4-(4-morpholinyl)phenyl]amino]-4-pyrimidinyl]amino]phenyl]methanesulfonamide hydrochloride;CZC-54252;N-(2-(5-chloro-2-(2-methoxy-4-morpholinophenylamino)pyrimidin-4-ylamino)phenyl)methanesulfonamide;CZC 54252 hydrochloride
|
C22H25ClN6O4S |
0 | |
|
SR9243
|
1613028-81-1 |
N/A
|
CS-1645;N-[2-(3-溴苯基)乙基]-2,4,6-三甲基-N-[[3'-(甲基磺酰基)[1,1'-联苯]-4-基]甲基]苯磺酰胺;SR 9243;SR9243;SR-9243
|
C31H32BrNO4S2 |
626.62408 | |
|
SRPIN 340
|
218156-96-8 |
SRPKINHIBITOR
|
CS-910;SRPIN 340;SRPIN-340;SRPK INHIBITOR;N-[2-(1-哌啶基)-5-(三氟甲基)苯基]-4-吡啶甲酰胺;N-(2-(哌啶-1-基)-5-(三氟甲基)苯基)异烟酰胺
|
C18H18F3N3O |
349.35023 | |
|
SBE-13 Hydrochloride
|
1052532-15-6 |
N/A
|
CS-1632;N-[[4-[(6-氯-3-吡啶基)甲氧基]-3-甲氧基苯基]甲基]-3,4-二甲氧基苯乙胺盐酸盐
|
C24H28Cl2N2O4 |
479.39612 | |
|
R-MG-132
|
1211877-36-9 |
N-[(苯基甲氧基)羰基]-L-亮氨酰-N-[(1S)-1-甲酰基-3-甲基丁基]-D-亮氨酰胺
|
N-[(苯基甲氧基)羰基]-L-亮氨酰-N-[(1S)-1-甲酰基-3-甲基丁基]-D-亮氨酰胺
|
C26H41N3O5 |
475.62084 | |
|
8-CHLOROADENOSINE
|
34408-14-5 |
8-氯腺嘌呤核苷
|
8-氯腺嘌呤核苷
|
C10H12N5O4Cl |
301.68638 | |
|
PU-H71
|
873436-91-0 |
6-氨基-8-[(6-碘-1,3-苯并二茂-5-基)硫基]-N-异丙基-9H-嘌呤-9-丙胺
|
6-氨基-8-[(6-碘-1,3-苯并二茂-5-基)硫基]-N-异丙基-9H-嘌呤-9-丙胺;CS-105
|
C18H21IN6O2S |
||
|
Tertiapin-Q
|
910044-56-3 |
托肽品 Q
|
托肽品 Q
|
C106H175N35O24S4 |
2452 | |
|
Somatostatin 1-28
|
74315-46-1 |
生长抑素(1-28)
|
生长抑素(1-28)
|
C137H207N41O39S3 |
3148.591 | |
|
Sodium phosphate monobasic
|
7558-80-7 |
磷酸二氢钠
|
无水磷酸二氢钠,CP,98.0%;无水磷酸二氢钠,USP;磷酸二氢钠,无水;磷酸一钠;磷酸二氢钠 无水;磷酸二氢钠,无水,ACS级试剂;无水磷酸二氢钠,FOR HPLC,≥99.0%(T);磷酸二氢钠,磷酸一钠
|
NAH2PO4 |
119.98 | 231-449-2 |
|
DMH4
|
515880-75-8 |
DMH-4
|
DMH-4
|
C24H24N4O2 |
400.47296 | |
|
Dorsomorphin 2Hydrochloride
|
1219168-18-9 |
BML-275
|
6-[4-(2-PIPERIDIN-1-YLETHOXY)PHENYL]-3-PYRIDIN-4-YLPYRAZOLO[1,5-A]PYRIMIDINE;DIHYDROCHLORIDE;BML-275;COMPOUND C;BML275;BML 275;CS-1883;6-[4-[2-(1-哌啶基)乙氧基]苯基]-3-(4-吡啶基)吡唑并[1,5-A]嘧啶二盐酸盐;BML-275 HCL,物质C盐酸盐;BML-275(2HCL);BML-275;COMPOUND C;BML275;BML 275;BML-275 DIHYDROCHLORIDE;COMPOUND C DIHYDROCHLORIDE;BML275 DIHYDROCHLORIDE;BML 275 DIHYDROCHLORIDE;DORSOMORPHIN (COMPOUND C)2HCL
|
C24H27Cl2N5O |
472.41008 | |
|
AEE788
|
497839-62-0 |
6-[4-[(4-乙基-1-哌嗪)甲基]苯基]-N-[(1R)-1-苯基乙基]-7H-吡咯并[2,3-D]嘧啶-4-胺
|
CS-375;6-[4-[(4-乙基-1-哌嗪)甲基]苯基]-N-[(1R)-1-苯基乙基]-7H-吡咯并[2,3-D]嘧啶-4-胺;AEE 788AEE-788;AEE788 (NVP-AEE788);AEE-788;AEE 788;NVP-AEE 788
|
C27H32N6 |
440.58318 | -0 |
|
PI-3065
|
955977-50-1 |
N/A
|
CS-1274;6-[[4-(环丙基甲基)-1-哌嗪基]甲基]-2-(5-氟-1H-吲哚-4-基)-4-(4-吗啉基)噻吩并[3,2-D]嘧啶
|
C27H31FN6OS |
506.638043 |
药智官方微信
药智官方微博
